These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28928847)

  • 1. Anti-angiogenic effect of arsenic trioxide in lung cancer via inhibition of endothelial cell migration, proliferation and tube formation.
    Yang MH; Chang KJ; Zheng JC; Huang H; Sun GY; Zhao XW; Li B; Xiu QY
    Oncol Lett; 2017 Sep; 14(3):3103-3109. PubMed ID: 28928847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer.
    Yang MH; Chang KJ; Li B; Chen WS
    Biomed Res Int; 2019; 2019():4647252. PubMed ID: 31093499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic Trioxide Restrains Lung Cancer Growth and Metastasis by Blocking the Calcineurin-NFAT Pathway by Upregulating DSCR1.
    Yang MH; Wang YS; Shi XQ; Zhao XW; Li B
    Curr Cancer Drug Targets; 2022; 22(10):854-864. PubMed ID: 35770414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis.
    Yang MH; Zang YS; Huang H; Chen K; Li B; Sun GY; Zhao XW
    Curr Cancer Drug Targets; 2014; 14(6):557-66. PubMed ID: 25088040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch pathway inhibition mediated by arsenic trioxide depletes tumor initiating cells in small cell lung cancer.
    Yang MH; Li B; Chang KJ
    Mol Biol Rep; 2022 Mar; 49(3):2245-2253. PubMed ID: 35028858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
    Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice.
    Xiao YF; Wu DD; Liu SX; Chen X; Ren LF
    World J Gastroenterol; 2007 Dec; 13(48):6498-505. PubMed ID: 18161919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiogenic growth factor combinations on retinal endothelial cells.
    Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
    Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dosage of arsenic trioxide (As
    Luo D; Zhang X; Du R; Gao W; Luo N; Zhao S; Li Y; Chen R; Wang H; Bao Y; Yang W; Liu D; Shen W
    J Biol Inorg Chem; 2018 Aug; 23(6):939-947. PubMed ID: 30014256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide inhibits cancer stem-like cells via down-regulation of Gli1 in lung cancer.
    Chang KJ; Yang MH; Zheng JC; Li B; Nie W
    Am J Transl Res; 2016; 8(2):1133-43. PubMed ID: 27158399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide inhibits angiogenesis in vitro and in vivo by upregulating FoxO3a.
    Sun Z; Li M; Bai L; Fu J; Lu J; Wu M; Zhou C; Zhang Y; Wu Y
    Toxicol Lett; 2019 Oct; 315():1-8. PubMed ID: 31421153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells.
    Zhang L; Liu L; Zhan S; Chen L; Wang Y; Zhang Y; Du J; Wu Y; Gu L
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide inhibits the growth of cancer stem cells derived from small cell lung cancer by downregulating stem cell-maintenance factors and inducing apoptosis via the Hedgehog signaling blockade.
    Chang KJ; Yin JZ; Huang H; Li B; Yang MH
    Transl Lung Cancer Res; 2020 Aug; 9(4):1379-1396. PubMed ID: 32953511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Arsenic Trioxide in the Treatment of Malignant Pleural Effusion Caused by Pleural Metastasis of Lung Cancer.
    Xie SL; Yang MH; Chen K; Huang H; Zhao XW; Zang YS; Li B
    Cell Biochem Biophys; 2015 Apr; 71(3):1325-33. PubMed ID: 25413961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiogenesis by arsenic trioxide
    Zhang J; Li C; Zheng Y; Lin Z; Zhang Y; Zhang Z
    Oncotarget; 2017 Sep; 8(43):73529-73546. PubMed ID: 29088724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
    Bai Y; Bai L; Zhou J; Chen H; Zhang L
    Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ABCG2 by nuclear factor kappa B affects the sensitivity of human lung adenocarcinoma A549 cells to arsenic trioxide.
    Jiang X; Chen C; Gu S; Zhang Z
    Environ Toxicol Pharmacol; 2018 Jan; 57():141-150. PubMed ID: 29274627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
    Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
    Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.